Good Publication Practice
GPP3
What a definition is not
A definition is SPEQ’s plain-language decode of how a term is used in practice, cited to the documents that define it. It is a practitioner reference, not legal or regulatory advice, it does not replace the definition in the source, and where a regulator’s wording differs the regulator’s wording governs.
The industry-authored discipline governing the ethical and transparent publication and communication of company-sponsored medical research — authorship criteria, disclosure of funding and conflicts of interest, timely reporting of results regardless of outcome, and avoidance of undue sponsor influence on interpretation, consistent with recognized authorship frameworks such as the ICMJE criteria.
Good Publication Practice addresses a stage of the medical-product lifecycle that sits outside manufacturing and clinical conduct entirely: how the results of company-sponsored studies are written up, credited, and disclosed to the scientific and medical community, including in journal articles, congress presentations, and clinical trial registries.
Its principles include following recognized authorship criteria (such as the ICMJE criteria), disclosing all funding sources and author conflicts of interest, committing to publish or otherwise disclose results regardless of whether they are favorable to the sponsor, and ensuring named authors — not the sponsor alone — retain control over interpretation and conclusions.
GPP guidance (most recently GPP3, and its planned successor GPP 2022) is not a regulatory requirement in the way GCP is, but it is widely adopted by pharmaceutical companies, medical writers, and journals as the expected professional standard, and is frequently referenced in company standard operating procedures for publications.
- —Governs how company-sponsored research is written up and disclosed, not how it is conducted
- —Requires recognized authorship criteria and full conflict-of-interest disclosure
- —Commits sponsors to disclose results regardless of outcome
- —An industry professional standard, not a codified health-authority regulation
Good Publication Practice for Communicating Company-Sponsored Medical Research (GPP3, 2015; industry-authored guideline)
Frequently asked questions
What does Good Publication Practice stand for?
Good Publication Practice stands for GPP3.
What is Good Publication Practice?
The industry-authored discipline governing the ethical and transparent publication and communication of company-sponsored medical research — authorship criteria, disclosure of funding and conflicts of interest, timely reporting of results regardless of outcome, and avoidance of undue sponsor influence on interpretation, consistent with recognized authorship frameworks such as the ICMJE criteria.
Which regulations cover Good Publication Practice?
Good Publication Practice for Communicating Company-Sponsored Medical Research (GPP3, 2015; industry-authored guideline)